Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Issa, Basil
ACSPIRE, NCT05436639 / 2022-000748-32: SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor	Active, not recruiting	2	30	Europe, US	SPI-62 dose	Sparrow Pharmaceuticals, Sparrow Pharmaceuticals, Inc.	Autonomous Cortisol Secretion (ACS), ACTH-Independent Cushing Syndrome, ACTH-Independent Adrenal Cushing Syndrome, Somatic	12/24	12/25
MIDDAS-GDM, NCT05344066: Manchester Intermittent Diet in Gestational Diabetes Acceptability Study	Active, not recruiting	N/A	26	Europe	Best NHS Care, Intermittent Low Energy Diet	Manchester University NHS Foundation Trust, National Institute for Health Research, United Kingdom, University of Manchester	Gestational Diabetes, Gestational Diabetes Mellitus in Pregnancy, Intermittent Fasting, Pregnancy Related, Diabetes, Diabetes in Pregnancy	07/24	07/24
MIDDAS T1, NCT04674384: Manchester Intermittent and Daily Diet Type 1 Diabetes App Study (MIDDAS-Type 1)	Recruiting	N/A	12	Europe	Optifast meal replacement shakes	Manchester University NHS Foundation Trust	Type 1 Diabetes, Obesity	04/24	04/24